SG11202111056YA - Methods for treatment of subjects with psoriatic arthritis - Google Patents

Methods for treatment of subjects with psoriatic arthritis

Info

Publication number
SG11202111056YA
SG11202111056YA SG11202111056YA SG11202111056YA SG11202111056YA SG 11202111056Y A SG11202111056Y A SG 11202111056YA SG 11202111056Y A SG11202111056Y A SG 11202111056YA SG 11202111056Y A SG11202111056Y A SG 11202111056YA SG 11202111056Y A SG11202111056Y A SG 11202111056YA
Authority
SG
Singapore
Prior art keywords
subjects
treatment
methods
psoriatic arthritis
psoriatic
Prior art date
Application number
SG11202111056YA
Inventor
Kirti Wardhaman Ganorkar
Atul Mathuradas Raut
Anil Raghavan
Siu-Long Yao
Original Assignee
Sun Pharmaceutical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Ind Ltd filed Critical Sun Pharmaceutical Ind Ltd
Publication of SG11202111056YA publication Critical patent/SG11202111056YA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG11202111056YA 2019-04-15 2020-04-15 Methods for treatment of subjects with psoriatic arthritis SG11202111056YA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201921015050 2019-04-15
IN202021004422 2020-01-31
PCT/IB2020/053565 WO2020212874A1 (en) 2019-04-15 2020-04-15 Methods for treatment of subjects with psoriatic arthritis

Publications (1)

Publication Number Publication Date
SG11202111056YA true SG11202111056YA (en) 2021-11-29

Family

ID=72837755

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202111056YA SG11202111056YA (en) 2019-04-15 2020-04-15 Methods for treatment of subjects with psoriatic arthritis

Country Status (14)

Country Link
US (1) US20220298233A1 (en)
EP (1) EP3956357A4 (en)
JP (1) JP2022529266A (en)
KR (1) KR20210140780A (en)
CN (1) CN113825768A (en)
AU (1) AU2020259375A1 (en)
BR (1) BR112021020612A2 (en)
CA (1) CA3143604A1 (en)
IL (1) IL287213A (en)
JO (1) JOP20210279A1 (en)
MA (1) MA55729A (en)
MX (1) MX2021012652A (en)
SG (1) SG11202111056YA (en)
WO (1) WO2020212874A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7807389B2 (en) * 2003-03-14 2010-10-05 University Of Rochester Methods and compositions related to joint inflammation diseases
WO2008063213A2 (en) * 2006-04-10 2008-05-29 Abbott Biotechnology Ltd. Uses and compositions for treatment of psoriatic arthritis
ATE554791T1 (en) * 2007-02-23 2012-05-15 Schering Corp GENETICALLY ENGINEERED ANTI-IL-23P19 ANTIBODIES
EP2331078B1 (en) * 2008-08-27 2012-09-19 Merck Sharp & Dohme Corp. Lyophilized formulations of engineered anti-il-23p19 antibodies
BR112013011065B1 (en) * 2010-11-04 2022-03-15 Boehringer Ingelheim International Gmbh Humanized anti-IL-23p19 antibody or its antigen-binding fragment, its use and pharmaceutical composition

Also Published As

Publication number Publication date
EP3956357A1 (en) 2022-02-23
US20220298233A1 (en) 2022-09-22
KR20210140780A (en) 2021-11-23
AU2020259375A1 (en) 2021-10-28
JP2022529266A (en) 2022-06-20
CA3143604A1 (en) 2020-10-22
JOP20210279A1 (en) 2023-01-30
CN113825768A (en) 2021-12-21
MX2021012652A (en) 2022-01-24
IL287213A (en) 2021-12-01
MA55729A (en) 2022-02-23
EP3956357A4 (en) 2023-01-04
BR112021020612A2 (en) 2021-12-28
WO2020212874A1 (en) 2020-10-22

Similar Documents

Publication Publication Date Title
ZA202100528B (en) Acid gas treatment
IL283948A (en) Methods for the treatment of depression
SG11202104222TA (en) Method of treatment of biological surfaces
IL259486A (en) Agents for the treatment of diseases associated with undesired cell proliferation
IL280440A (en) Industrial equipment for the treatment of produce
IL291735A (en) Heteroaryl-biphenyl amines for the treatment of pd-l1 diseases
IL286653A (en) Methods for treating muscular dystrophy with casimersen
GB202015959D0 (en) Treatment of diseases involving NAD
IL284791A (en) Methods of treating disease with magl inhibitors
GB201808575D0 (en) Methods for the treatment of psoriatic arthrits
HUP1800109A2 (en) Process and equipment for the treatment of biomass
IL311200A (en) Methods for the treatment of cb1-, trpa1- and trpv1-dependent conditions
IL286099A (en) Methods of treating disease with levoketoconazole
IL287213A (en) Methods for treatment of subjects with psoriatic arthritis
IL281480B (en) Process and apparatus for the treatment of organic feedstock
EP3599288C0 (en) Diagnosis and treatment of psoriatic arthritis
IL286000A (en) Esketamine for the treatment of depression
PL3292226T3 (en) Method for the treatment of iron-containing sludge
SG11202110776TA (en) Methods for the treatment of beta-thalassemia
GB201911056D0 (en) Treatment of ADD/ADHD
IL269681A (en) New methods for the treatment of multiple sclerosis
PL3431656T3 (en) Method for the treatment of ballast
IL290983A (en) Methods of treatment
GB201918853D0 (en) Methods of treatment
GB201902634D0 (en) Apparatus for the treatment of malaria